BIOCRYST PHARMACEUTICALS INC's ticker is BCRX and the CUSIP is 09058V103. A total of 118 filers reported holding BIOCRYST PHARMACEUTICALS INC in Q2 2019. The put-call ratio across all filers is 1.77 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2019 | $51,000 | -54.5% | 17,700 | +28.5% | 0.00% | -66.7% |
| Q1 2019 | $112,000 | +33.3% | 13,774 | +32.5% | 0.00% | 0.0% |
| Q4 2018 | $84,000 | -51.7% | 10,398 | -65.7% | 0.00% | 0.0% |
| Q2 2018 | $174,000 | +222.2% | 30,300 | +193.4% | 0.00% | +200.0% |
| Q3 2017 | $54,000 | -67.3% | 10,328 | -28.7% | 0.00% | -75.0% |
| Q3 2015 | $165,000 | -76.7% | 14,482 | -69.5% | 0.00% | -71.4% |
| Q2 2015 | $709,000 | +99.7% | 47,500 | -79.3% | 0.01% | -30.0% |
| Q2 2013 | $355,000 | – | 229,064 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| VHCP Management II, LLC | 6,071,142 | $38,430,000 | 18.43% |
| RTW INVESTMENTS, LP | 4,078,895 | $25,819,000 | 9.72% |
| VHCP Management, LLC | 1,155,104 | $7,312,000 | 7.86% |
| RA Capital Management | 2,989,795 | $18,925,000 | 2.68% |
| DLD Asset Management, LP | 1,258,700 | $7,967,000 | 2.61% |
| Avoro Capital Advisors LLC | 1,631,502 | $10,327,000 | 2.09% |
| Ghost Tree Capital, LLC | 1,150,000 | $7,280,000 | 1.75% |
| GREAT POINT PARTNERS LLC | 725,000 | $4,589,000 | 0.94% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 3,237,734 | $20,495,000 | 0.84% |
| Baker Brothers Advisors | 10,963,944 | $69,402,000 | 0.68% |